Phelityl® Cleansing Oil | Erno Laszlo

Cosmetic whose composition was read from the brand website (website recognised under its name)

Has the product changed? Photograph the packaging.

Points to note

None of the 29 recognised names is prohibited in all cases in European Union cosmetics; 1 unrecognized name could not be checked.

Who it concerns

For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.

Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.

• Skin, eyes and allergies

  • Worth watching Parfum (Fragrance)“Parfum” stands for a mixture whose composition does not have to be detailed. Some allergenic substances must nevertheless be named separately in the ingredient list above 0.001% (leave-on product) or 0.01% (rinse-off product). The Regulation names them in 63 entries of its Annex III, for example Linalool, Limonene, Citronellol, Geraniol, Coumarin, Citral, Eugenol or Hexyl Cinnamal: if you are allergic to one of them, look for its name in the list.
  • Worth watching CitronellolAllergen to declare: Annex III, entry 86, requires it to be named in the ingredient list above 0.001% in a leave-on product and 0.01% in a rinse-off product, so that allergic people can avoid it.
  • Worth watching CoumarinAllergen to declare: Annex III, entry 77, requires it to be named in the ingredient list above 0.001% in a leave-on product and 0.01% in a rinse-off product, so that allergic people can avoid it.
  • Worth watching LinaloolClassified under the CLP Regulation: skin sensitisation, category 1B (Skin Sens. 1B). Allergen to declare: Annex III, entry 84, requires it to be named in the ingredient list above 0.001% in a leave-on product and 0.01% in a rinse-off product, so that allergic people can avoid it.
  • Worth watching Alpha-isomethyl IononeAllergen to declare: Annex III, entry 90, requires it to be named in the ingredient list above 0.001% in a leave-on product and 0.01% in a rinse-off product, so that allergic people can avoid it.
  • Worth watching Benzyl SalicylateClassified under the CLP Regulation: skin sensitisation, category 1B (Skin Sens. 1B). Allergen to declare: Annex III, entry 75, requires it to be named in the ingredient list above 0.001% in a leave-on product and 0.01% in a rinse-off product, so that allergic people can avoid it.

No official text covers the recognised ingredients for: pregnancy and breastfeeding, babies and children, environment, read on the label.

For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.

Recorded composition

List recorded on 25 October 2026, before new cosmetic regulation deadlines: CITRONELLOL (Annex III, entry 86): sale of a non-compliant product prohibited from 1 August 2028 ; BENZYL SALICYLATE (Annex III, entry 75): placing on the market of a non-compliant product prohibited from 1 January 2027, sale of a non-compliant product prohibited from 1 July 2028, sale of a non-compliant product prohibited from 1 August 2028. The formula may have changed: check the label of the product on sale.

29 recognised ingredients out of 30.

Hover over or tap a badge for its meaning.

Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.